Korea University Guro Hospital
🇰🇷South Korea
Clinical Trials
88
Active:3
Completed:39
Trial Phases
5 Phases
Early Phase 1:1
Phase 1:1
Phase 2:8
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (67 trials with phase data)• Click on a phase to view related trials
Not Applicable
34 (50.7%)Phase 4
23 (34.3%)Phase 2
8 (11.9%)Early Phase 1
1 (1.5%)Phase 1
1 (1.5%)Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
Not Applicable
Recruiting
- Conditions
- PainChronic PainOpioid AnalgesiaOpioid Use
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT07102446
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer
Completed
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 339
- Registration Number
- NCT07099105
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy
Completed
- Conditions
- Lung Cancer
- First Posted Date
- 2025-06-08
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 865
- Registration Number
- NCT07009769
- Locations
- 🇰🇷
Korea University Guro Hospital, Guro-gu, Seoul, Korea, Republic of
Efficacy and Safety of CBT on Tinnitus
Not Applicable
Completed
- Conditions
- Tinnitus
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06889259
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Cardiac Stunning After Electrical Cardioversion
Active, not recruiting
- Conditions
- Atrial Fibrillation (AF)
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT06752733
- Locations
- 🇰🇷
Korea University Medicine Guro hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
News
Onconic's Jaqbo Shows 100% Efficacy in Phase 3 Gastric Ulcer Trial, Seeks Indication Expansion
Onconic Therapeutics has submitted an application to MFDS to expand Jaqbo's indication to include gastric ulcer treatment, following successful Phase 3 trial results showing 100% healing rate at 8 weeks.